newsfilter
← Latest News
Business Wire·

Rallybio to Present at Upcoming Investor Conferences

Rallybio Corporation (NASDAQ:RLYB), a clinical-stage biotechnology company translating scientific advances into transformative therapies for patients with devastating rare diseases, today announced its participation in